Detalhe da pesquisa
1.
CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer.
Cell
; 159(5): 1126-1139, 2014 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25416950
2.
BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells.
Nature
; 572(7771): 676-680, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31391581
3.
mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis.
Nature
; 561(7724): 556-560, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30232453
4.
Distinct neuroblastoma-associated alterations of PHOX2B impair sympathetic neuronal differentiation in zebrafish models.
PLoS Genet
; 9(6): e1003533, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23754957
5.
A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma.
Cancer Immunol Immunother
; 64(10): 1251-60, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26105625
6.
Activating mutations in ALK provide a therapeutic target in neuroblastoma.
Nature
; 455(7215): 975-8, 2008 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-18923525
7.
The MYCN 5' UTR as a therapeutic target in neuroblastoma.
Cell Rep
; 43(5): 114134, 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662542
8.
Small-molecule inhibition of the METTL3/METTL14 complex suppresses neuroblastoma tumor growth and promotes differentiation.
Cell Rep
; 43(5): 114165, 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38691450
9.
CKLF instigates a "cold" microenvironment to promote MYCN-mediated tumor aggressiveness.
Sci Adv
; 10(11): eadh9547, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38489372
10.
Emerging importance of ALK in neuroblastoma.
Semin Cancer Biol
; 21(4): 267-75, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21945349
11.
Tumor histology during induction therapy in patients with high-risk neuroblastoma.
Pediatr Blood Cancer
; 59(3): 506-10, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22162143
12.
Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switch.
J Immunother Cancer
; 10(12)2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36521927
13.
Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypes.
Nat Cancer
; 3(10): 1228-1246, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36138189
14.
Synergistic Anti-Tumor Effect of Combining Selective CDK7 and BRD4 Inhibition in Neuroblastoma.
Front Oncol
; 11: 773186, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35198433
15.
Giotto: a toolbox for integrative analysis and visualization of spatial expression data.
Genome Biol
; 22(1): 78, 2021 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33685491
16.
Extracellular domain shedding of the ALK receptor mediates neuroblastoma cell migration.
Cell Rep
; 36(2): 109363, 2021 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34260934
17.
Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma.
Mol Cancer
; 9: 277, 2010 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20950435
18.
Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: a Children's Oncology Group study.
Pediatr Blood Cancer
; 55(4): 629-38, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20589651
19.
Formation of Human Neuroblastoma in Mouse-Human Neural Crest Chimeras.
Cell Stem Cell
; 26(4): 579-592.e6, 2020 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32142683
20.
Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma.
Eur J Cancer
; 136: 52-68, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32653773